Great Lakes Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.2M | Sell |
49,000
-6,210
| -11% | -$659K | 0.04% | 278 |
|
|
2025
Q1 | $6.85M | Buy |
55,210
+18,768
| +52% | +$2.33M | 0.06% | 232 |
|
|
2024
Q4 | $4.49M | Buy |
+36,442
| New | +$4.49M | 0.04% | 335 |
|
|
2024
Q1 | – | Sell |
-5,435
| Closed | -$669K | – | 834 |
|
|
2023
Q4 | $669K | Sell |
5,435
-2,539
| -32% | -$312K | 0.01% | 573 |
|
|
2023
Q3 | $1.03M | Sell |
7,974
-4,384
| -35% | -$567K | 0.01% | 523 |
|
|
2023
Q2 | $1.53M | Sell |
12,358
-29,066
| -70% | -$3.6M | 0.02% | 478 |
|
|
2023
Q1 | $6.06M | Buy |
41,424
+39,796
| +2,444% | +$5.82M | 0.06% | 326 |
|
|
2022
Q4 | $259K | Buy |
1,628
+42
| +3% | +$6.69K | 0.01% | 582 |
|
|
2022
Q3 | $211K | Buy |
1,586
+110
| +7% | +$14.6K | ﹤0.01% | 599 |
|
|
2022
Q2 | $230K | Sell |
1,476
-261
| -15% | -$40.7K | ﹤0.01% | 617 |
|
|
2022
Q1 | $270K | Buy |
+1,737
| New | +$270K | ﹤0.01% | 618 |
|
|
2014
Q4 | – | Sell |
-4,865
| Closed | -$781K | – | 537 |
|
|
2014
Q3 | $781K | Buy |
+4,865
| New | +$781K | 0.03% | 340 |
|